Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Trisomy 13 in which the presence of an extra copy of chromosome 13 is present in all the cells of the organism.
Biomarker and diagnostic research for complete trisomy 13 has been reported in the published literature.
No clinical trials have been registered for complete trisomy 13.
4 publications have been identified in PubMed for complete trisomy 13. Research spans Diagnostic / Biomarker (25%), Review / Meta-Analysis (25%), and Case Report / Case Series (25%).
Chen CP (2026). [PMID: 42036207](https://pubmed.ncbi.nlm.nih.gov/42036207/). *Taiwan J Obstet Gynecol*. [Case Report / Case Series]
Wong EC (2026). [PMID: 41557440](https://pubmed.ncbi.nlm.nih.gov/41557440/). *Otol Neurotol*. [Basic Science / Preclinical]
Siddik AB (2026). [PMID: 32644517](https://pubmed.ncbi.nlm.nih.gov/32644517/). *Unknown Journal*. [Review / Meta-Analysis]
Kunanukulwatana C (2025). [PMID: 40491497](https://pubmed.ncbi.nlm.nih.gov/40491497/). *Int J Womens Health*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 9:11 PM UTC
Common questions about complete trisomy 13
AI-curated news mentioning complete trisomy 13
Updated Sep 15, 2026
A recent study evaluates the impact of screening programs on the prenatal diagnosis rates of trisomy 13 and 18 over 30 years. The findings highlight trends in detection rates, providing insights for future screening strategies.